Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model

被引:50
作者
Cameron, Mark J. [1 ]
Kelvin, Alyson A. [9 ]
Leon, Alberto J. [1 ,4 ]
Cameron, Cheryl M. [1 ]
Ran, Longsi [1 ]
Xu, Luoling [1 ]
Chu, Yong-Kyu [5 ]
Danesh, Ali [1 ,3 ]
Fang, Yuan [1 ,3 ]
Li, Qianjun [5 ]
Anderson, Austin [5 ]
Couch, Ronald C. [6 ]
Paquette, Stephane G. [1 ,2 ]
Fomukong, Ndingsa G. [6 ]
Kistner, Otfried [8 ]
Lauchart, Manfred [8 ]
Rowe, Thomas [1 ]
Harrod, Kevin S. [6 ]
Jonsson, Colleen B. [7 ]
Kelvin, David J. [1 ,2 ,3 ,4 ,6 ,10 ]
机构
[1] Toronto Gen Hosp, Div Expt Therapeut, Res Inst, Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Dept Immunol, Fac Med, Toronto, ON, Canada
[4] Shantou Univ, Int Inst Infect & Immun, Coll Med, Shantou, Guangdong, Peoples R China
[5] So Res Inst, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA
[6] Lovelace Resp Res Inst, Albuquerque, NM USA
[7] Ctr Predict Med, Louisville, KY USA
[8] Baxter Innovat GmbH, Vienna, Austria
[9] Immune Diagnost & Res, Toronto, ON, Canada
[10] Univ Sassari, Sez Microbiol Sperimentale & Clin, Dipartimento Sci Biomed, I-07100 Sassari, Italy
来源
PLOS ONE | 2012年 / 7卷 / 09期
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
ACUTE RESPIRATORY SYNDROME; IMMUNE-RESPONSES; INFLUENZA-VIRUS; MICE; PATHOGENESIS; MECHANISMS; CYTOKINES; EVENTS; FAMILY; ISG15;
D O I
10.1371/journal.pone.0045842
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In terms of its highly pathogenic nature, there remains a significant need to further define the immune pathology of SARS-coronavirus (SARS-CoV) infection, as well as identify correlates of immunity to help develop vaccines for severe coronaviral infections. Here we use a SARS-CoV infection-reinfection ferret model and a functional genomics approach to gain insight into SARS immunopathogenesis and to identify correlates of immune protection during SARS-CoV-challenge in ferrets previously infected with SARS-CoV or immunized with a SARS virus vaccine. We identified gene expression signatures in the lungs of ferrets associated with primary immune responses to SARS-CoV infection and in ferrets that received an identical second inoculum. Acute SARS-CoV infection prompted coordinated innate immune responses that were dominated by antiviral IFN response gene (IRG) expression. Reinfected ferrets, however, lacked the integrated expression of IRGs that was prevalent during acute infection. The expression of specific IRGs was also absent upon challenge in ferrets immunized with an inactivated, Al(OH)(3)-adjuvanted whole virus SARS vaccine candidate that protected them against SARS-CoV infection in the lungs. Lack of IFN-mediated immune enhancement in infected ferrets that were previously inoculated with, or vaccinated against, SARS-CoV revealed 9 IRG correlates of protective immunity. This data provides insight into the molecular pathogenesis of SARS-CoV and SARS-like-CoV infections and is an important resource for the development of CoV antiviral therapeutics and vaccines.
引用
收藏
页数:16
相关论文
共 52 条
  • [41] Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines
    See, Raymond H.
    Petric, Martin
    Lawrence, David J.
    Mok, Catherine P. Y.
    Rowe, Thomas
    Zitzow, Lois A.
    Karunakaran, Karuna P.
    Voss, Thomas G.
    Brunham, Robert C.
    Gauldie, Jack
    Finlay, B. Brett
    Roper, Rachel L.
    [J]. JOURNAL OF GENERAL VIROLOGY, 2008, 89 : 2136 - 2146
  • [42] Successful Vaccination Strategies That Protect Aged Mice from Lethal Challenge from Influenza Virus and Heterologous Severe Acute Respiratory Syndrome Coronavirus
    Sheahan, Timothy
    Whitmore, Alan
    Long, Kristin
    Ferris, Martin
    Rockx, Barry
    Funkhouser, William
    Donaldson, Eric
    Gralinski, Lisa
    Collier, Martha
    Heise, Mark
    Davis, Nancy
    Johnston, Robert
    Baric, Ralph S.
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (01) : 217 - 230
  • [43] A double-inactivated whole virus candidate SARS coronavirus vaccine
    Spruth, M
    Kistner, O
    Savidis-Dacho, H
    Hitter, E
    Crowe, B
    Gerencer, M
    Brühl, P
    Grillberger, L
    Reiter, M
    Tauer, C
    Mundt, W
    Barrett, PN
    [J]. VACCINE, 2006, 24 (05) : 652 - 661
  • [44] Interferon signalling network in innate defence
    Takaoka, A
    Yanai, H
    [J]. CELLULAR MICROBIOLOGY, 2006, 8 (06) : 907 - 922
  • [45] IRF family of transcription factors as regulators of host defense
    Taniguchi, T
    Ogasawara, K
    Takaoka, A
    Tanaka, N
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 623 - 655
  • [46] SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
    Totura, Allison L.
    Baric, Ralph S.
    [J]. CURRENT OPINION IN VIROLOGY, 2012, 2 (03) : 264 - 275
  • [47] Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003
    Vega, VB
    Ruan, YJ
    Liu, JJ
    Lee, WH
    Wei, CL
    Se-Thoe, SY
    Tang, KF
    Zhang, T
    Kolatkar, PR
    Ooi, EE
    Ling, AE
    Stanton, LW
    Long, PM
    Liu, ET
    [J]. BMC INFECTIOUS DISEASES, 2004, 4 (1)
  • [48] REL/NF-KAPPA-B/I-KAPPA-B FAMILY - INTIMATE TALES OF ASSOCIATION AND DISSOCIATION
    VERMA, IM
    STEVENSON, JK
    SCHWARZ, EM
    VANANTWERP, D
    MIYAMOTO, S
    [J]. GENES & DEVELOPMENT, 1995, 9 (22) : 2723 - 2735
  • [49] Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
    Weingartl, H
    Czub, M
    Czub, S
    Neufeld, J
    Marszal, P
    Gren, J
    Smith, G
    Jones, S
    Proulx, R
    Deschambault, Y
    Grudeski, E
    Andonov, A
    He, RT
    Li, Y
    Copps, J
    Grolla, A
    Dick, D
    Berry, J
    Ganske, S
    Manning, L
    Cao, JX
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (22) : 12672 - 12676
  • [50] Mice susceptible to SARS coronavirus
    Wentworth, DE
    Gillim-Ross, L
    Espina, N
    Bernard, KA
    [J]. EMERGING INFECTIOUS DISEASES, 2004, 10 (07) : 1293 - 1296